Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Terheyden

Showing results (41-50 of 130) with videos related to

Pageof 13
Sort By:
Frontiers in Medicine|July 22, 2021
Serum Troponin T Concentrations Are Frequently Elevated in Advanced Skin Cancer Patients Prior to Immune Checkpoint Inhibitor Therapy: Experience From a Single Tertiary Referral CenterJonas K Kurzhals, Tobias Graf, Katharina Boch, et al.
The Journal of Dermatology|June 21, 2022
Challenge of hepatitis B testing following intravenous immunoglobulin therapy in patients with autoimmune skin diseasesJasper N Pruessmann, Ewan A Langan, Jan Rupp, et al.
Journal of the American Academy of Dermatology|June 21, 2024
Pemphigoid gestationis is associated with an increased risk for adverse pregnancy outcomes: A large-scale propensity-matched retrospective cohort studySophie L Preuß, Artem Vorobyev, Eva Lotta Moderegger, et al.
Frontiers in Medicine|April 2, 2019
Immune Cell Infiltration of the Primary Tumor, Not PD-L1 Status, Is Associated With Improved Response to Checkpoint Inhibition in Metastatic MelanomaChristiane Kümpers, Mladen Jokic, Ozan Haase, et al.
Dermatology and Therapy|September 13, 2023
Varicella Zoster Virus-Specific Hyperimmunoglobulin in the Adjuvant Treatment of Immunocompromised Herpes Zoster Patients: A Case SeriesPatrick Terheyden, Cord Sunderkötter, Franz-Dietmar Söhngen, et al.
Acta Dermato-Venereologica|May 28, 2015
Increased expression of caspase-1 and interleukin-18 in peeling skin disease, and a novel mutation of corneodesmosinFrederic Valentin, Vinzenz Oji, Ingrid Hausser, et al.
Ebiomedicine|April 17, 2024
Increased cardiovascular risks and mortality in prurigo nodularis: a global cohort studyHenning Olbrich, Khalaf Kridin, Gema Hernández, et al.
European Journal of Immunology|December 13, 2005
Expression of the NKG2D ligand UL16 binding protein-1 (ULBP-1) on dendritic cellsDavid Schrama, Patrick Terheyden, Kerstin Otto, et al.
Frontiers in Medicine|October 24, 2025
Increased risk of deep vein thrombosis, pulmonary embolism, and all-cause mortality in chronic venous disorder: a large-scale retrospective cohort studyEva Lotta Moderegger, Sören Dräger, Sophie L Preuss, et al.
Advances in Therapy|July 9, 2020
Patients with BRAF-Mutant Advanced/Metastatic Melanoma: Original Research on the Treatment Reality in Germany and Austria in the Era of ChoiceSebastian Haferkamp, Mareike Alter, Dirk Debus, et al.
Pageof 13

Showing results (41-50 of 130) with videos related to

Sort By:
Pageof 13
Frontiers in Medicine|July 22, 2021
Serum Troponin T Concentrations Are Frequently Elevated in Advanced Skin Cancer Patients Prior to Immune Checkpoint Inhibitor Therapy: Experience From a Single Tertiary Referral CenterJonas K Kurzhals, Tobias Graf, Katharina Boch, et al.
The Journal of Dermatology|June 21, 2022
Challenge of hepatitis B testing following intravenous immunoglobulin therapy in patients with autoimmune skin diseasesJasper N Pruessmann, Ewan A Langan, Jan Rupp, et al.
Journal of the American Academy of Dermatology|June 21, 2024
Pemphigoid gestationis is associated with an increased risk for adverse pregnancy outcomes: A large-scale propensity-matched retrospective cohort studySophie L Preuß, Artem Vorobyev, Eva Lotta Moderegger, et al.
Frontiers in Medicine|April 2, 2019
Immune Cell Infiltration of the Primary Tumor, Not PD-L1 Status, Is Associated With Improved Response to Checkpoint Inhibition in Metastatic MelanomaChristiane Kümpers, Mladen Jokic, Ozan Haase, et al.
Dermatology and Therapy|September 13, 2023
Varicella Zoster Virus-Specific Hyperimmunoglobulin in the Adjuvant Treatment of Immunocompromised Herpes Zoster Patients: A Case SeriesPatrick Terheyden, Cord Sunderkötter, Franz-Dietmar Söhngen, et al.
Acta Dermato-Venereologica|May 28, 2015
Increased expression of caspase-1 and interleukin-18 in peeling skin disease, and a novel mutation of corneodesmosinFrederic Valentin, Vinzenz Oji, Ingrid Hausser, et al.
Ebiomedicine|April 17, 2024
Increased cardiovascular risks and mortality in prurigo nodularis: a global cohort studyHenning Olbrich, Khalaf Kridin, Gema Hernández, et al.
European Journal of Immunology|December 13, 2005
Expression of the NKG2D ligand UL16 binding protein-1 (ULBP-1) on dendritic cellsDavid Schrama, Patrick Terheyden, Kerstin Otto, et al.
Frontiers in Medicine|October 24, 2025
Increased risk of deep vein thrombosis, pulmonary embolism, and all-cause mortality in chronic venous disorder: a large-scale retrospective cohort studyEva Lotta Moderegger, Sören Dräger, Sophie L Preuss, et al.
Advances in Therapy|July 9, 2020
Patients with BRAF-Mutant Advanced/Metastatic Melanoma: Original Research on the Treatment Reality in Germany and Austria in the Era of ChoiceSebastian Haferkamp, Mareike Alter, Dirk Debus, et al.
Pageof 13